These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 16144944)
41. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627 [TBL] [Abstract][Full Text] [Related]
42. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer. Younes MN; Yazici YD; Kim S; Jasser SA; El-Naggar AK; Myers JN Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3425-34. PubMed ID: 16740767 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery. Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740 [TBL] [Abstract][Full Text] [Related]
44. Downregulation of EGFR by a novel multivalent nanobody-liposome platform. Oliveira S; Schiffelers RM; van der Veeken J; van der Meel R; Vongpromek R; van Bergen En Henegouwen PM; Storm G; Roovers RC J Control Release; 2010 Jul; 145(2):165-75. PubMed ID: 20362020 [TBL] [Abstract][Full Text] [Related]
45. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers. Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253 [TBL] [Abstract][Full Text] [Related]
46. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer. Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673 [TBL] [Abstract][Full Text] [Related]
47. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Goldstein NI; Prewett M; Zuklys K; Rockwell P; Mendelsohn J Clin Cancer Res; 1995 Nov; 1(11):1311-8. PubMed ID: 9815926 [TBL] [Abstract][Full Text] [Related]
48. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993 [TBL] [Abstract][Full Text] [Related]
49. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers. Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621 [TBL] [Abstract][Full Text] [Related]
50. Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent. Asano R; Sone Y; Makabe K; Tsumoto K; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I Clin Cancer Res; 2006 Jul; 12(13):4036-42. PubMed ID: 16818703 [TBL] [Abstract][Full Text] [Related]
51. Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts. Salcedo R; Martins-Green M; Gertz B; Oppenheim JJ; Murphy WJ Clin Cancer Res; 2002 Aug; 8(8):2655-65. PubMed ID: 12171898 [TBL] [Abstract][Full Text] [Related]
52. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene. Johns TG; Stockert E; Ritter G; Jungbluth AA; Huang HJ; Cavenee WK; Smyth FE; Hall CM; Watson N; Nice EC; Gullick WJ; Old LJ; Burgess AW; Scott AM Int J Cancer; 2002 Mar; 98(3):398-408. PubMed ID: 11920591 [TBL] [Abstract][Full Text] [Related]
53. Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor. Steiner P; Joynes C; Bassi R; Wang S; Tonra JR; Hadari YR; Hicklin DJ Clin Cancer Res; 2007 Mar; 13(5):1540-51. PubMed ID: 17332300 [TBL] [Abstract][Full Text] [Related]
54. Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy. Mendelsohn J Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2703-7. PubMed ID: 10068277 [TBL] [Abstract][Full Text] [Related]
55. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor. Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389 [TBL] [Abstract][Full Text] [Related]
56. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Wikstrand CJ; McLendon RE; Friedman AH; Bigner DD Cancer Res; 1997 Sep; 57(18):4130-40. PubMed ID: 9307304 [TBL] [Abstract][Full Text] [Related]
57. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas. Tysnes BB; Haugland HK; Bjerkvig R Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221 [TBL] [Abstract][Full Text] [Related]
59. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice. Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355 [TBL] [Abstract][Full Text] [Related]
60. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]